Stock A299660 CELLID, CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Cellid, Co., Ltd.

Equities

A299660

KR7299660001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
3,835 KRW +1.72% Intraday chart for Cellid, Co., Ltd. -0.90% -14.21%
2023 Cellid, Co., Ltd.(KOSDAQ:A299660) dropped from S&P Global BMI Index CI
2021 Private S.Korea firms plan $5.4 billion investment to create vaccine hub RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cellid, Co., Ltd.(KOSDAQ:A299660) dropped from S&P Global BMI Index
CI
Private S.Korea firms plan $5.4 billion investment to create vaccine hub
RE
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June
RE
Cellid, Co., Ltd. announced that it has received KRW 19 billion in funding
CI
Cellid, Co., Ltd. announced that it expects to receive KRW 19 billion in funding
CI
Cellid, Inc.(KOSDAQ:A299660) added to S&P Global BMI Index
CI
Cellid, Inc.(KOSDAQ:A299660) added to S&P Global BMI Index
CI
Cellid, Inc.(KOSDAQ:A299660) added to S&P Global BMI Index
CI
Cellid, Inc. has completed an IPO in the amount of KRW 39.6 billion.
CI
Cellid, Inc. has filed an IPO.
CI
Cellid Co., Ltd. announced that it has received KRW 1.50 billion in funding from Amicogen Inc.
CI
Cellid Co., Ltd. announced that it expects to receive KRW 1.50 billion in funding from Amicogen Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A299660 Stock
  4. News Cellid, Co., Ltd.